Locus Biosciences Revenue and Competitors
Estimated Revenue & Valuation
- Locus Biosciences's estimated annual revenue is currently $5.4M per year.
- Locus Biosciences's estimated revenue per employee is $77,500
- Locus Biosciences's total funding is $93.7M.
Employee Data
- Locus Biosciences has 70 Employees.
- Locus Biosciences grew their employee count by -15% last year.
Locus Biosciences's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Co-founder and CEO | Reveal Email/Phone |
2 | VP | Reveal Email/Phone |
3 | Associate VP, Research and Development Program Managment | Reveal Email/Phone |
4 | VP Pharmaceutical Operations and Technology | Reveal Email/Phone |
5 | VP, Research and Development | Reveal Email/Phone |
6 | VP Clinical Development | Reveal Email/Phone |
7 | VP Clinical Operations and CMC Operations | Reveal Email/Phone |
8 | Director Automation and Informatics | Reveal Email/Phone |
9 | Director R&D | Reveal Email/Phone |
10 | Director Automation and Informatics | Reveal Email/Phone |
Locus Biosciences Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $11.2M | 72 | -13% | N/A | N/A |
#2 | $5099.8M | 32902 | -4% | N/A | N/A |
#3 | $1.7M | 11 | 0% | N/A | N/A |
#4 | $0.6M | 4 | -56% | N/A | N/A |
#5 | $0.9M | 11 | -39% | N/A | N/A |
#6 | $1.7M | 11 | 10% | N/A | N/A |
#7 | $0.6M | 4 | -33% | N/A | N/A |
#8 | $4.8M | 31 | -6% | N/A | N/A |
#9 | $6.4M | 41 | 3% | N/A | N/A |
#10 | $4.2M | 27 | -18% | N/A | N/A |
What Is Locus Biosciences?
Locus Biosciences’ novel approach to precision antimicrobials works by taking advantage of an immune system present in many bacteria called the CRISPR-Cas system. The CRISPR-Cas system protects bacteria from invaders such as viruses by creating a small strand of RNA called a CRISPR RNA, which matches a DNA sequence specific to a given invader. If the CRISPR RNA is matched to a complementary DNA sequence, the Cas proteins will cleave the invading DNA.
keywords:N/A
$93.7M
Total Funding
70
Number of Employees
$5.4M
Revenue (est)
-15%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Locus Biosciences News
... Proteon Pharmaceuticals, Phagelux, Intralytix, Micreos, Eliava BioPreparations, Locus Biosciences,Inc, Pharmex Group,LLC and many more.
EpiBiome, a South San Francisco, CA-based precision microbiome engineering company, completed a $6m Series A financing. Backers included Viking Global Investors via the Illumina Accelerator Boost Capital, Matrix Capital Management, Alexandria Venture Investments, SV Tech Ventures and China Rock ...
Other Companies in Morrisville
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $9.3M | 71 | -3% | N/A |
#2 | $20.8M | 72 | -4% | N/A |
#3 | $11.8M | 73 | 14% | N/A |
#4 | $15M | 73 | 11% | N/A |
#5 | $18M | 74 | 48% | N/A |